BET inhibitor suppresses melanoma progression <i>via</i> the noncanonical NF-κB/SPP1 pathway
Guangtong Deng, Furong Zeng, Juan Su, Shuang Zhao, Rui Hu, Wu Zhu, Shuo Hu, Xiang Chen, Mingzhu Yin
Abstract
the noncanonical NF-κB/SPP1 pathway.
Topics & Concepts
Cancer researchNF-κBMelanomaChemistryMedicineSignal transductionBiochemistryProtein Degradation and InhibitorsUbiquitin and proteasome pathwaysCAR-T cell therapy research